Global Ganja Report

Among the multiple grim challenges facing humanity at this moment is the specter of "antibiotic apocalypse"—so-called "superbugs" developing resistance to common antibiotics, portending a plague of incurable infections. Research in Australia now reveals anti-bacterial properties in CBD, effective even against the growing ranks of resistant superbugs. Many in the stateside cannabis industry say the development is further evidence that legal barriers to research need to come down—and fast.

The US Surgeon General has launched a new campaign hyping the supposed dangers of cannabis—a further disappointment for activists who held out hope that Trump harbored libertarian instincts and would legalize. All too predictably, the anti-legalization assumptions behind the new campaign are amply refuted by actual research.

Advocates increasingly assert that cannabis legalization is not fully realized unless workers are guaranteed their right to employment even if they partake of the herb off-hours. Some states are finally taking measures to rein in the use of urine-test results as an excuse to fire or turn down job applicants.

Driven by the notorious market glut in Oregon, wholesale cannabis prices have predictably plunged in the Beaver State. They have done so less precipitously in other western states. But this is offset by continued high prices elsewhere in the country, especially the East Coast—making for an overall upward trend this year.

Over the past weeks, dozens of people across several states have experienced serious lung problems, even requiring hospitalization, apparently after using vape cartridges. It is unclear if cannabis products were at issue in all such cases, and authorities are still investigating. But the illicit market in unregulated knock-off dab carts may be to blame.

The prosecutor for Miami-Dade County is the latest of several around the country to halt minor cannabis cases. The move was prompted by a dilemma vexing law enforcement nationwide: the inability to distinguish between THC and legal CBD in confiscated samples.

In Washington state, glitches in the "seed-to-sale" tracking system nearly paralyzed the cannabis industry statewide last month, costing retailers hundreds of thousands of dollars and forcing temporary lay-offs of employees. Similar headlines have been seen from across the country's legalized states—pointing to a persistent issue.

The US Department of Agriculture is opening an Industrial Hemp Germplasm Repository, in conjunction with upstate New York's Cornell University. The facility is envisioned as a major hub for genetic analysis and research, helping to spur the hemp industry's growth regionally and nationally.